Side-by-side comparison of AI visibility scores, market position, and capabilities
Jackson MI Michigan regulated utility (NYSE: CMS) ~$8.4B FY2024 revenue; Consumers Energy 6.8M customers, 18 consecutive earnings guidance years, PA 235 clean energy 2040 mandate competing with DTE Energy.
CMS Energy Corporation is a Jackson, Michigan-based regulated electric and gas utility holding company — publicly traded on the New York Stock Exchange (NYSE: CMS) as an S&P 500 Utilities component — serving approximately 6.8 million electric and 1.8 million natural gas customers throughout Michigan through its principal subsidiary Consumers Energy (Michigan's largest utility, serving 68 of Michigan's 83 counties) through approximately 7,500 employees. In fiscal year 2024, CMS Energy reported revenues of approximately $8.4 billion and adjusted EPS of approximately $3.29, growing within the company's 6-8% annual adjusted EPS guidance range that has made CMS Energy one of the most consistent earnings growth utilities in the US — delivering 18 consecutive years of meeting or exceeding earnings guidance under the management team's "CE Way" lean operational improvement program. CEO Garrick Rochow leads CMS Energy's strategy of executing a $20+ billion capital plan (2024-2028) focused on renewable energy generation (wind and solar replacing coal-fired generation ahead of the Michigan Public Service Commission's clean energy mandate), electric distribution grid hardening (replacing 1,750 miles of distribution lines annually to reduce storm outage frequency and duration), and natural gas infrastructure modernization. Michigan's Governor Whitmer's 100% clean energy by 2040 mandate (PA 235 — enacted 2023) requires Consumers Energy to retire coal plants, add significant renewable energy generation, and build battery storage — translating directly into approved rate base capital investment that earns Consumers Energy's authorized return on equity (approximately 9.9%).
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.